IL190245A0 - Iontophoretic drug delivery system - Google Patents

Iontophoretic drug delivery system

Info

Publication number
IL190245A0
IL190245A0 IL190245A IL19024508A IL190245A0 IL 190245 A0 IL190245 A0 IL 190245A0 IL 190245 A IL190245 A IL 190245A IL 19024508 A IL19024508 A IL 19024508A IL 190245 A0 IL190245 A0 IL 190245A0
Authority
IL
Israel
Prior art keywords
delivery system
drug delivery
iontophoretic drug
iontophoretic
drug
Prior art date
Application number
IL190245A
Original Assignee
Tti Ellebeau Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tti Ellebeau Inc filed Critical Tti Ellebeau Inc
Publication of IL190245A0 publication Critical patent/IL190245A0/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/044—Shape of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47—Quinolines; Isoquinolines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0009—Galenical forms characterised by the drug release technique; Application systems commanded by energy involving or responsive to electricity, magnetism or acoustic waves; Galenical aspects of sonophoresis, iontophoresis, electroporation or electroosmosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0021—Intradermal administration, e.g. through microneedle arrays, needleless injectors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0432—Anode and cathode
    • A61N1/0436—Material of the electrode
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0444—Membrane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/02—Details
    • A61N1/04—Electrodes
    • A61N1/0404—Electrodes for external use
    • A61N1/0408—Use-related aspects
    • A61N1/0428—Specially adapted for iontophoresis, e.g. AC, DC or including drug reservoirs
    • A61N1/0448—Drug reservoir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/20—Applying electric currents by contact electrodes continuous direct currents
    • A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
    • A61N1/303—Constructional details
    • A61N1/306—Arrangements where at least part of the apparatus is introduced into the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00—Electrotherapy; Circuits therefor
    • A61N1/18—Applying electric currents by contact electrodes
    • A61N1/32—Applying electric currents by contact electrodes alternating or intermittent currents
    • A61N1/36—Applying electric currents by contact electrodes alternating or intermittent currents for stimulation
    • A61N1/36014—External stimulators, e.g. with patch electrodes
    • A61N1/36021—External stimulators, e.g. with patch electrodes for treatment of pain
IL190245A 2005-09-30 2008-03-18 Iontophoretic drug delivery system IL190245A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US72213605P 2005-09-30 2005-09-30
PCT/US2006/038549 WO2007041544A1 (en) 2005-09-30 2006-09-29 Transdermal drug delivery systems, devices, and methods employing opioid agonist and/or opioid antagonist

Publications (1)

Publication Number Publication Date
IL190245A0 true IL190245A0 (en) 2008-11-03

Family

ID=37696075

Family Applications (1)

Application Number Title Priority Date Filing Date
IL190245A IL190245A0 (en) 2005-09-30 2008-03-18 Iontophoretic drug delivery system

Country Status (10)

Country Link
EP (1) EP1931421A1 (en)
JP (1) JP2009509692A (en)
KR (1) KR20080058433A (en)
CN (2) CN101316623A (en)
AU (1) AU2006299521A1 (en)
BR (1) BRPI0616788A2 (en)
CA (1) CA2622684A1 (en)
IL (1) IL190245A0 (en)
RU (1) RU2008117168A (en)
WO (1) WO2007041544A1 (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20100239523A1 (en) * 2007-10-30 2010-09-23 The Regents Of The University Of Colorado Tlr modulators and methods for using the same
AU2009225434B2 (en) 2008-03-21 2014-05-22 The University Of Chicago Treatment with opioid antagonists and mTOR inhibitors
WO2010036401A1 (en) 2008-05-01 2010-04-01 The Regents Of The University Of California Methods and compositions using selective delta opioid receptor-1 agonists, delta opioid receptor-2 antagonists, and/or mu opioid receptor antagonists for treatment of substance-related disorders
JP4779084B2 (en) * 2009-03-25 2011-09-21 国立大学法人 香川大学 Microneedle, manufacturing method thereof and mold
WO2013006643A1 (en) 2011-07-06 2013-01-10 The Parkinson's Institute Compositions and methods for treatment of symptoms in parkinson's disease patients
US10213586B2 (en) 2015-01-28 2019-02-26 Chrono Therapeutics Inc. Drug delivery methods and systems
AU2016228779A1 (en) 2015-03-12 2017-09-07 Chrono Therapeutics Inc. Craving input and support system
CN106730311B (en) * 2016-12-27 2019-10-29 潍坊大地医疗器械有限公司 Comprehensive channel therapeutic apparatus electrode contact apparatus
US11285306B2 (en) 2017-01-06 2022-03-29 Morningside Venture Investments Limited Transdermal drug delivery devices and methods
GB201704909D0 (en) 2017-03-28 2017-05-10 Ldn Pharma Ltd Cancer therapy
WO2019090125A2 (en) * 2017-11-02 2019-05-09 Chrono Therapeutics Inc. Smart abuse-deterrent transdermal drug delivery system
JP7420797B2 (en) 2018-05-29 2024-01-23 モーニングサイド ベンチャー インベストメンツ リミテッド Drug delivery methods and systems
AU2020226862B2 (en) * 2019-02-21 2021-11-11 Pharmaceutical Productions, Inc. Naloxone formulations for sublingual and/or buccal administration

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4626539A (en) * 1984-08-10 1986-12-02 E. I. Dupont De Nemours And Company Trandermal delivery of opioids
US4722726A (en) * 1986-02-12 1988-02-02 Key Pharmaceuticals, Inc. Method and apparatus for iontophoretic drug delivery
US4879297A (en) * 1987-06-01 1989-11-07 Warner-Lambert Company Fatty acids and their small chain esters as penetration enhancers in aqueous systems
US5312326A (en) * 1992-06-02 1994-05-17 Alza Corporation Iontophoretic drug delivery apparatus
GEP20125454B (en) * 2003-07-25 2012-03-26 Euro Celtique Sa Treatment of drug dependence withdrawal
TW200640526A (en) * 2005-02-24 2006-12-01 Alza Corp Transdermal electrotransport drug delivery systems with reduced abuse potential

Also Published As

Publication number Publication date
EP1931421A1 (en) 2008-06-18
CN101321554A (en) 2008-12-10
CN101316623A (en) 2008-12-03
CA2622684A1 (en) 2007-04-12
BRPI0616788A2 (en) 2011-07-05
RU2008117168A (en) 2009-11-10
WO2007041544A1 (en) 2007-04-12
JP2009509692A (en) 2009-03-12
AU2006299521A1 (en) 2007-04-12
KR20080058433A (en) 2008-06-25

Similar Documents

Publication Publication Date Title
EP1901796A4 (en) Drug delivery system
EP2178598A4 (en) Iontophoretic drug delivery system
EP1848749A4 (en) Contact drug delivery system
IL190245A0 (en) Iontophoretic drug delivery system
IL184824A0 (en) Infusion delivery system
GB2442875B (en) Regulated drug delivery system
IL169807A (en) Drug delivery device
EP1793865A4 (en) Gene or drug delivery system
EP1773240A4 (en) Silk-based drug delivery system
IL187457A0 (en) Breath actuated drug delivery system
GB0522569D0 (en) Biocompatible drug delivery device
IL177785A0 (en) Nanocell drug delivery system
ZA201002014B (en) Drug delivery system
SI1631255T1 (en) Drug delivery system
IL198911A0 (en) Drug delivery
EP1755732A4 (en) Multiple unit dose drug delivery system
EP1858483A4 (en) Delivery system for multiple drugs
GB0517035D0 (en) Delivery system
HK1202083A1 (en) Iontophoretic drug delivery system
PT1957073E (en) Medicinal drug
IL176395A0 (en) Nicotine transdermal delivery system
EP1858493A4 (en) Oral drug delivery system
EP2226083A4 (en) Drug delivery system
GB0515363D0 (en) Drug delivery system
GB0401008D0 (en) Drug delivery system